Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Neurotoxicity Syndromes × Cytarabine × Clear all

Phase

Status

Withdrawn 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurotoxicity Syndromes 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Burkitt Lymphoma 1

Interventions

Prednisolone 1 Methylprednisolone 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended

LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡